Loading...
Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats
Pulmonary fibrosis is an irreversible chronic progressive fibroproliferative lung disease, which usually has a poor prognosis. Previous studies have confirmed that the transplantation of bone marrow mesenchymal stem cells (MSCs) significantly reduces lung damage in a number of animal models. However...
Saved in:
Published in: | Mol Med Rep |
---|---|
Main Authors: | , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
D.A. Spandidos
2015
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4270324/ https://ncbi.nlm.nih.gov/pubmed/25411925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2014.2981 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|